Singular Genomics Systems Inc (OMIC)
21.90
+0.22
(+1.01%)
USD |
NASDAQ |
Nov 21, 16:00
Singular Genomics Systems Profit Margin (Quarterly): -4.14K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.14K% |
| June 30, 2024 | -2.88K% |
| March 31, 2024 | -5.66K% |
| December 31, 2023 | -2.15K% |
| Date | Value |
|---|---|
| September 30, 2023 | -4.84K% |
| June 30, 2023 | -5.06K% |
| March 31, 2023 | -2.74K% |
| December 31, 2022 | -2.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.66K%
Minimum
Mar 2024
-2.15K%
Maximum
Dec 2023
-3.78K%
Average
-3.51K%
Median
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 4.73% |
| Azenta Inc | -2.93% |
| Harvard Bioscience Inc | -21.86% |
| Bionano Genomics Inc | -728.6% |
| Akoya Biosciences Inc | -55.98% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.24% |
| Return on Assets | -36.10% |
| Return on Invested Capital | -51.76% |
| Gross Profit Margin (Quarterly) | -74.14% |
| Operating Margin (Quarterly) | -4.45K% |
| Return on Net Operating Assets | -83.99% |